BioHarvest Sciences Inc. Common Stock
$4.42
▼
-0.7%
2026-04-21 05:39:01
www.bioharvest.com
NGM: BHST
Explore BioHarvest Sciences Inc. Common Stock stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$115.99 M
Current Price
$4.42
52W High / Low
$8.05 / $7.95
Stock P/E
—
Book Value
$1.12
Dividend Yield
—
ROCE
-13.94%
ROE
-83.17%
Face Value
—
EPS
$-0.6
Exp Qtr EPS
—
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
89
Beta
1.4
Debt / Equity
55.42
Current Ratio
3.97
Quick Ratio
3.38
Forward P/E
-107.75
Price / Sales
2.83
Enterprise Value
$88.77 M
EV / EBITDA
-17.37
EV / Revenue
2.57
Rating
Strong Buy
Target Price
$12.75
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | The Kraft Heinz Company | $21.98 | — | $26.07 B | 7.2% | 6.35% | -12.84% | $30.42 / $21.04 | $35.19 |
| 2. | The Campbell's Company | $21.26 | 11.47 | $6.31 B | 7.43% | 11.28% | 13.89% | $38.27 / $19.76 | $13.44 |
| 3. | Beyond Meat, Inc. | $1.16 | 2.48 | $537.73 M | — | -25.32% | 28.76% | $7.69 / $0.5 | $0 |
| 4. | Arcadia Biosciences, Inc. | $1.11 | — | $2.29 M | — | -222.75% | -45.14% | $6.71 / $0.89 | $3.02 |
| 5. | SRx Health Solutions Inc. | $0.12 | — | $37.87 M | — | -234.74% | 164.52% | $2.16 / $0.08 | $-0.11 |
| 6. | DDC Enterprise Limited | $2.05 | — | $61.56 M | — | -60.66% | -42.7% | $20.83 / $1.62 | $3.26 |
| 7. | McCormick & Company, Incorporated | $0 | — | — | — | 10.77% | 25.35% | — / — | $25.98 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 9.07 M | 9.07 M | 8.52 M | 7.86 M | 7.28 M | — |
| Operating Profit | -1.12 M | -0.92 M | -1.81 M | -1.72 M | -1.69 M | — |
| Net Profit | -2.2 M | -2.51 M | -4.08 M | -2.34 M | -2.96 M | — |
| EPS in Rs | -0.1 | -0.11 | -0.18 | -0.1 | -0.13 | -0.16 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 34.51 M | 25.19 M | 12.67 M | 5.5 M |
| Operating Profit | -5.58 M | -6.99 M | -9.97 M | -10.61 M |
| Net Profit | -11.13 M | -12.91 M | -12.56 M | -11.24 M |
| EPS in Rs | -0.49 | -0.57 | -0.55 | -0.5 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 47.66 M | 25 M | 15 M | 9.39 M |
| Total Liabilities | 22.22 M | 23.67 M | 29.86 M | 15.32 M |
| Equity | 25.45 M | 1.33 M | -14.85 M | -5.93 M |
| Current Assets | 30.5 M | 7.86 M | 9.05 M | 4.32 M |
| Current Liabilities | 7.68 M | 14.26 M | 26.47 M | 11.52 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.23 M | -6.68 M | -8.52 M | -9.24 M |
| Investing CF | -2.37 M | -3.03 M | -1.47 M | -1.26 M |
| Financing CF | 30.19 M | 6.78 M | 13.56 M | 8.14 M |
| Free CF | -9.58 M | -9.52 M | -10 M | -10.5 M |
| Capex | -2.35 M | -2.83 M | -1.47 M | -1.26 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 98.77% | 130.48% | — | — |
| Earnings Growth % | -2.78% | -11.82% | — | — |
| Profit Margin % | -51.27% | -99.15% | -204.37% | — |
| Operating Margin % | -27.75% | -78.65% | -193.02% | — |
| Gross Margin % | 55.35% | 44.45% | 22.17% | — |
| EBITDA Margin % | -27.46% | -77.04% | -165.97% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.